Carregant...
An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness assessment (REA) for pharmaceuticals and medical devices. This cooperation is operationalised through a proposal for a regulation. While a good step in the right direction, this HT...
Guardat en:
| Publicat a: | Eur J Health Econ |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438931/ https://ncbi.nlm.nih.gov/pubmed/30868380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10198-019-01037-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|